R44CA141845
|
Department of Health and Human Services
|
93.395 - CANCER TREATMENT RESEARCH
|
2009-09-01
|
2013-08-31
|
CDK3-INHIBITING ANTICANCER AGENTS
|
|
Recipient |
SENEX BIOTECHNOLOGY INC
|
Recipient Name Raw |
SENEX BIOTECHNOLOGY INC
|
Recipient UEI |
G8XKMW3DYMQ6
|
Recipient DUNS |
170943240
|
Recipient Address |
150 NEW SCOTLAND AVENUE, ALBANY, ALBANY, NEW YORK, 12208-3425, UNITED STATES
|
Obligated Amount |
1538623.00
|
Non-Federal Funding |
0.00
|
Original Subsidy Cost |
0.00
|
Face Value of Direct Loan |
0.00
|
Link |
View Page
|
|
R43CA141845
|
Department of Health and Human Services
|
93.395 - CANCER TREATMENT RESEARCH
|
2009-09-01
|
2010-08-31
|
CDK3-INHIBITING ANTICANCER AGENTS
|
|
Recipient |
SENEX BIOTECHNOLOGY INC
|
Recipient Name Raw |
SENEX BIOTECHNOLOGY INC
|
Recipient UEI |
G8XKMW3DYMQ6
|
Recipient DUNS |
170943240
|
Recipient Address |
150 NEW SCOTLAND AVENUE, ALBANY, ALBANY, NEW YORK, 12208-3425, UNITED STATES
|
Obligated Amount |
107000.00
|
Non-Federal Funding |
0.00
|
Original Subsidy Cost |
0.00
|
Face Value of Direct Loan |
0.00
|
Link |
View Page
|
|
W81XWH0810611
|
Department of Defense
|
12.420 - MILITARY MEDICAL RESEARCH AND DEVELOPMENT
|
2008-08-15
|
2009-09-14
|
BREAST TUMOR GROWTH INHIBITION BY BLOCKING CYTOKINE EXPRESSION IN STROMAL FIBROBLASTS
|
|
Recipient |
SENEX BIOTECHNOLOGY INC
|
Recipient Name Raw |
SENEX BIOTECHNOLOGY
|
Recipient UEI |
G8XKMW3DYMQ6
|
Recipient DUNS |
170943240
|
Recipient Address |
150 NEW SCOTLAND, ALBANY, ALBANY, NEW YORK, 12208-3425, UNITED STATES
|
Obligated Amount |
90000.00
|
Non-Federal Funding |
0.00
|
Original Subsidy Cost |
0.00
|
Face Value of Direct Loan |
0.00
|
Link |
View Page
|
|
R43GM081968
|
Department of Health and Human Services
|
93.859 - BIOMEDICAL RESEARCH AND RESEARCH TRAINING
|
2008-02-01
|
2008-07-31
|
SMALL MOLECULES INDUCING BTG1 TRANSCRIPTION
|
|
Recipient |
SENEX BIOTECHNOLOGY INC
|
Recipient Name Raw |
SENEX BIOTECHNOLOGY INC
|
Recipient UEI |
G8XKMW3DYMQ6
|
Recipient DUNS |
170943240
|
Recipient Address |
150 NEW SCOTLAND AVENUE, ALBANY, ALBANY, NEW YORK, 12208
|
Obligated Amount |
107001.00
|
Non-Federal Funding |
0.00
|
Original Subsidy Cost |
0.00
|
Face Value of Direct Loan |
0.00
|
Link |
View Page
|
|
R44CA139991
|
Department of Health and Human Services
|
93.395 - CANCER TREATMENT RESEARCH
|
2006-08-01
|
2010-08-31
|
INHIBITORS OF DISEASE-PROMOTING ACTIVITIES OF SENESCENCE
|
|
Recipient |
SENEX BIOTECHNOLOGY INC
|
Recipient Name Raw |
SENEX BIOTECHNOLOGY INC
|
Recipient UEI |
G8XKMW3DYMQ6
|
Recipient DUNS |
170943240
|
Recipient Address |
150 NEW SCOTLAND AVENUE, ALBANY, ALBANY, NEW YORK, 12208
|
Obligated Amount |
1002501.00
|
Non-Federal Funding |
0.00
|
Original Subsidy Cost |
0.00
|
Face Value of Direct Loan |
0.00
|
Link |
View Page
|
|